Clinical update on head and neck cancer: molecular biology and ongoing challenges

E Alsahafi, K Begg, I Amelio, N Raulf, P Lucarelli… - Cell death & …, 2019 - nature.com
Head and neck squamous cell carcinomas (HNSCCs) are an aggressive, genetically
complex and difficult to treat group of cancers. In lieu of truly effective targeted therapies …

Inside the hypoxic tumour: reprogramming of the DDR and radioresistance

K Begg, M Tavassoli - Cell Death Discovery, 2020 - nature.com
The hypoxic tumour is a chaotic landscape of struggle and adaption. Against the adversity of
oxygen starvation, hypoxic cancer cells initiate a reprogramming of transcriptional activities …

[HTML][HTML] Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors

P Kosti, JW Opzoomer, KI Larios-Martinez… - Cell Reports …, 2021 - cell.com
Utilizing T cells expressing chimeric antigen receptors (CARs) to identify and attack solid
tumors has proven challenging, in large part because of the lack of tumor-specific targets to …

Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy

R Abou Khouzam, HV Goutham, RF Zaarour… - Seminars in cancer …, 2020 - Elsevier
Immunotherapy is poised to become an increasingly utilized therapy in the treatment of
cancer. However, several abnormalities in the tumor microenvironment (TME) that can …

PET/CT and PET/MRI in head and neck malignancy

TA Szyszko, GJR Cook - Clinical radiology, 2018 - Elsevier
Combined 2-[18 F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography
(PET)/computed tomography (CT) has an established role in the staging of difficult cases of …

[HTML][HTML] Lost in application: Measuring hypoxia for radiotherapy optimisation

N Thiruthaneeswaran, BAS Bibby, L Yang… - European Journal of …, 2021 - Elsevier
The history of radiotherapy is intertwined with research on hypoxia. There is level 1a
evidence that giving hypoxia-targeting treatments with radiotherapy improves locoregional …

Clinical imaging of hypoxia: Current status and future directions

P Bonnitcha, S Grieve, G Figtree - Free Radical Biology and Medicine, 2018 - Elsevier
Tissue hypoxia is a key feature of many important causes of morbidity and mortality. In
pathologies such as stroke, peripheral vascular disease and ischaemic heart disease …

Hypoxia gene expression signatures as predictive biomarkers for personalising radiotherapy

L Yang, CML West - The British journal of radiology, 2018 - academic.oup.com
Hypoxia is a generic micro-environmental factor of solid tumours. High levels of hypoxia
lead to resistance to radiotherapy, which can be targeted by adding hypoxia-modifying …

A prognostic gene expression signature for oropharyngeal squamous cell carcinoma

X Liu, P Liu, RD Chernock, KAL Kuhs, JS Lewis… - …, 2020 - thelancet.com
Background Robust prognostic stratification of patients with oropharyngeal squamous cell
carcinoma (OPSCC) is important for develo** individualized treatment plans. This study …

[HTML][HTML] STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression

J Wang, J Shen, K Zhao, J Hu, J Dong… - Cancer Biology & …, 2019 - ncbi.nlm.nih.gov
Objective Stromal interaction molecule 1 (STIM1) overexpression has been reported to play
an important role in progression of several cancers. However, the mechanism of STIM1 …